News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

Tocagen is looking for patients with recurrent high grade glioma (glioblastoma or anaplastic astrocytoma) and caregivers to participate in an advisory board event in San Diego from March 20-21st.

Al's Comment:

 From our friends at Tocagen!  Sounds like an exciting meeting!


Posted on: 02/22/2019

FEBRUARY 21, 2019- Tocagen is looking for patients with recurrent high grade glioma (glioblastoma or anaplastic astrocytoma) and caregivers to participate in an advisory board event in San Diego from March 20-21st.  The purpose of this advisory board is to learn more about the patient journey and experience with high grade glioma, and to create an accurate patient journey map.  Tocagen is looking to interview patients in a one hour phone conversation to discuss their journey, and if qualified, invite participants to come to the March event.  Please reach out to elaine@pharmectionsllc.com for more information.  

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740